☰

Cheng Cheng - Publications

Affiliations: 
Biostatistics St. Jude Children's Research Hospital, San Francisco, CA, United States 
Tree Info Similar researchers PubMed Report error

158 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zhang H, Liu AP, Devidas M, Lee SHR, Cao X, Pei D, Borowitz M, Wood B, Gastier-Foster JM, Dai Y, Raetz E, Larsen E, Winick N, Bowman WP, Karol S, ... ... Cheng C, et al. Association of GATA3 polymorphisms with minimal residual disease and relapse risk in childhood acute lymphoblastic leukemia. Journal of the National Cancer Institute. PMID 32894760 DOI: 10.1093/Jnci/Djaa138  0.382
2020 Autry RJ, Paugh SW, Carter R, Shi L, Liu J, Ferguson DC, Lau CE, Bonten EJ, Yang W, McCorkle JR, Beard JA, Panetta JC, Diedrich JD, Crews KR, Pei D, ... ... Cheng C, et al. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia. Nature Cancer. 1: 329-344. PMID 32885175 DOI: 10.1038/S43018-020-0037-3  0.307
2020 Smith WT, Shiao KT, Varotto E, Zhou Y, Iijima M, Anghelescu DL, Cheng C, Jeha S, Pui CH, Kaste SC, Inaba H. Evaluation of Chest Radiographs of Children with Newly Diagnosed Acute Lymphoblastic Leukemia. The Journal of Pediatrics. 223: 120-127.e3. PMID 32711740 DOI: 10.1016/J.Jpeds.2020.04.003  0.322
2020 Talleur AC, Flerlage JE, Shook DR, Chilsen AM, Hudson MM, Cheng C, Huang S, Triplett BM. Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience. Bone Marrow Transplantation. PMID 32273588 DOI: 10.1038/S41409-020-0879-4  0.323
2020 Pedrosa F, Coustan-Smith E, Zhou Y, Cheng C, Pedrosa A, Lins MM, Pedrosa MF, Lucena-Silva N, Ramos AML, Vinhas Marques EAL, Rivera GK, Campana D, Ribeiro RC. Reduced-dose-intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study. Blood. PMID 32027741 DOI: 10.1182/Blood.2019004215  0.363
2020 Sharma A, Huang S, Talleur AC, Qudeimat A, Srinivasan A, Mamcarz E, Madden R, Li Y, Cheng C, Gottschalk S, Triplett BM. Second Allogeneic Hematopoietic Cell Transplant Is a Successful Salvage Modality for Pediatric Patients Who Relapse after First Transplant Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.586  0.313
2019 Gartrell J, Kaste SC, Sandlund JT, Flerlage J, Zhou Y, Cheng C, Estepp J, Metzger ML. The association of mediastinal mass in the formation of thrombi in pediatric patients with non-lymphoblastic lymphomas. Pediatric Blood & Cancer. e28057. PMID 31736198 DOI: 10.1002/Pbc.28057  0.331
2019 Li B, Brady SW, Ma X, Shen S, Zhang Y, Li Y, Szlachta K, Dong L, Liu Y, Yang F, Wang N, Flasch DA, Myers MA, Mulder HL, Ding L, ... ... Cheng C, et al. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia. Blood. PMID 31697823 DOI: 10.1182/Blood.2019002220  0.325
2019 Jeha S, Pei D, Choi J, Cheng C, Sandlund JT, Coustan-Smith E, Campana D, Inaba H, Rubnitz JE, Ribeiro RC, Gruber TA, Raimondi SC, Khan RB, Yang JJ, Mullighan CG, et al. Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901692. PMID 31657981 DOI: 10.1200/Jco.19.01692  0.34
2019 Finch ER, Smith CA, Yang W, Liu Y, Kornegay NM, Panetta JC, Crews KR, Molinelli AR, Cheng C, Pei D, Ramsey LB, Karol SE, Inaba H, Sandlund JT, Metzger M, et al. Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia. Pediatric Blood & Cancer. e28040. PMID 31612640 DOI: 10.1002/Pbc.28040  0.351
2019 Pui CH, Pei D, Cheng C, Tomchuck SL, Evans SN, Inaba H, Jeha S, Raimondi SC, Choi JK, Thomas PG, Dallas MH. Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor. Oncoimmunology. 8: 1599637. PMID 31413907 DOI: 10.1080/2162402X.2019.1599637  0.311
2019 Iacobucci I, Wen J, Meggendorfer M, Choi JK, Shi L, Pounds SB, Carmichael CL, Masih KE, Morris SM, Lindsley RC, Janke LJ, Alexander TB, Song G, Qu C, Li Y, ... ... Cheng C, et al. Genomic subtyping and therapeutic targeting of acute erythroleukemia. Nature Genetics. 51: 694-704. PMID 30926971 DOI: 10.1038/S41588-019-0375-1  0.326
2019 Robinson KM, Yang W, Karol SE, Kornegay N, Jay D, Cheng C, Choi JK, Campana D, Pui CH, Wood B, Borowitz MJ, Gastier-Foster J, Larsen EC, Winick N, Carroll WL, et al. No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. Pediatric Blood & Cancer. e27681. PMID 30848065 DOI: 10.1002/Pbc.27681  0.305
2019 Cai J, Yu J, Zhu X, Hu S, Zhu Y, Jiang H, Li C, Fang Y, Liang C, Ju X, Tian X, Zhai X, Hao J, Hu Q, Wang N, ... ... Cheng C, et al. Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children's Cancer Group. Archives of Disease in Childhood. PMID 30705079 DOI: 10.1136/Archdischild-2018-316181  0.332
2019 Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, ... Cheng C, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nature Genetics. PMID 30643249 DOI: 10.1038/S41588-018-0315-5  0.303
2019 Zhu X, Shen S, Cai J, Hu S, Gao J, Zhang H, Fang Y, Ju X, Zhai X, Wu X, Liang C, Tian X, Hu Q, Wang N, Jin R, ... ... Cheng C, et al. Lack of Benefit of Extended Vincristine and Dexamethasone Pulses during Maintenance Treatment of Childhood Acute Lymphoblastic Leukemia: A Multicenter Randomized Controlled Study of Chinese Children Cancer Group (CCCG)-ALL-2015 Blood. 134: 2576-2576. DOI: 10.1182/Blood-2019-128523  0.321
2019 Roberts KG, Brady SW, Gu Z, Shi L, Pounds S, Pei D, Cheng C, Dai Y, Devidas M, Qu C, Hill A, Ma X, Wei L, Arunachalam S, Hagiwara K, et al. The Genomic Landscape of Childhood Acute Lymphoblastic Leukemia Blood. 134: 649-649. DOI: 10.1182/Blood-2019-124881  0.36
2019 Hu Y, Chen A, Zheng X, Lu J, He H, Yang J, Zhang Y, Sui P, Yang J, He F, Wang Y, Xiao P, Liu X, Zhou Y, Pei D, ... Cheng C, et al. Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapy National Science Review. 6: 469-479. DOI: 10.1093/Nsr/Nwz006  0.372
2018 Chellapandian D, Hines MR, Zhang R, Jeng M, van den Bos C, Santa-María López V, Lehmberg K, Sieni E, Wang Y, Nakano T, Williams JA, Fustino NJ, Astigarraga I, Dunkel IJ, Abla O, ... ... Cheng C, et al. A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis. Cancer. PMID 30521100 DOI: 10.1002/Cncr.31893  0.304
2018 Browne EK, Zhou Y, Chemaitilly W, Panetta JC, Ness KK, Kaste SC, Cheng C, Relling MV, Pui CH, Inaba H. Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia. Cancer. PMID 30358906 DOI: 10.1002/Cncr.31736  0.332
2018 Robinson KM, Yang W, Haidar CE, Hankins JS, Jay DW, Kornegay N, Rubnitz JE, Broeckel U, Cheng C, Pui CH, Jeha S, Relling MV. Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies. The Pharmacogenomics Journal. PMID 30206300 DOI: 10.1038/S41397-018-0043-3  0.316
2018 Cao X, George EO, Wang M, Armstrong DB, Cheng C, Raimondi S, Rubnitz JE, Downing JR, Kundu M, Pounds SB. POST: a framework for set-based association analysis in high-dimensional data. Methods (San Diego, Calif.). PMID 29777750 DOI: 10.1016/J.Ymeth.2018.05.011  0.322
2018 Cheung YT, Khan RB, Liu W, Brinkman TM, Edelmann MN, Reddick WE, Pei D, Panoskaltsis-Mortari A, Srivastava D, Cheng C, Robison LL, Hudson MM, Pui CH, Krull KR. Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia. Jama Oncology. PMID 29596541 DOI: 10.1001/Jamaoncol.2018.0089  0.339
2018 Qian M, Cao X, Devidas M, Yang W, Cheng C, Dai Y, Carroll A, Heerema NA, Zhang H, Moriyama T, Gastier-Foster JM, Xu H, Raetz E, Larsen E, Winick N, et al. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017755215. PMID 29300620 DOI: 10.1200/Jco.2017.75.5215  0.4
2018 Finch ER, Smith CA, Yang W, Kornegay NM, Panetta JC, Crews KR, Molinelli AR, Cheng C, Pei D, Ramsey LB, Karol SE, Inaba H, Sandlund JT, Metzger M, Evans WE, et al. The Effect of Asparaginase on Serum Triglycerides during Therapy for Acute Lymphoblastic Leukemia Blood. 132: 2665-2665. DOI: 10.1182/Blood-2018-99-117093  0.322
2018 Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, ... Cheng C, et al. Characterization of Novel Subtypes in B Progenitor Acute Lymphoblastic Leukemia Blood. 132: 565-565. DOI: 10.1182/Blood-2018-99-111219  0.332
2018 Liu Y, Smith CA, Yang W, Thompson L, Dash A, Counts J, Chung M, Molinelli AR, Pei D, Kornegay NM, Springer EA, Panetta JC, Crews KR, Swanson H, Cheng C, et al. Pegaspargase Allergic Reactions Are Related to Anti-Pegaspargase Antibodies and to Intensity of Intrathecal Therapy Blood. 132: 2697-2697. DOI: 10.1182/Blood-2018-99-110141  0.312
2018 Karol S, Estepp J, Pei D, Cheng C, Relling M, Jeha S, Pui C. Venous Thrombosis in Children Treated for Acute Lymphoblastic Leukemia on St. Jude Total Therapy Studies Clinical Lymphoma, Myeloma & Leukemia. 18. DOI: 10.1016/J.Clml.2018.07.008  0.341
2017 Inaba H, Cao X, Han AQ, Panetta JC, Ness KK, Metzger ML, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Cheng C, Pui CH, Relling MV, Kaste SC. Bone mineral density in children with acute lymphoblastic leukemia. Cancer. PMID 29266176 DOI: 10.1002/Cncr.31184  0.321
2017 Bainer RO, Trendowski MR, Cheng C, Pei D, Yang W, Paugh SW, Goss KH, Skol AD, Pavlidis P, Pui CH, Gilliam TC, Evans WE, Onel K. A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia. Cancer Management and Research. 9: 397-410. PMID 28979163 DOI: 10.2147/Cmar.S139864  0.362
2017 Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, McCastlain K, Edmonson M, Pounds SB, Shi L, Zhou X, Ma X, Sioson E, Li Y, Rusch M, ... ... Cheng C, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nature Genetics. PMID 28671688 DOI: 10.1038/Ng.3909  0.302
2017 Ramsey LB, Pounds S, Cheng C, Cao X, Yang W, Smith C, Karol SE, Liu C, Panetta JC, Inaba H, Rubnitz JE, Metzger ML, Ribeiro RC, Sandlund JT, Jeha S, et al. Genetics of pleiotropic effects of dexamethasone. Pharmacogenetics and Genomics. PMID 28628558 DOI: 10.1097/Fpc.0000000000000293  0.343
2017 Liu Y, Fernandez CA, Smith C, Yang W, Cheng C, Panetta JC, Kornegay N, Liu C, Ramsey LB, Karol SE, Janke LJ, Larsen EC, Winick N, Carroll WL, Loh ML, et al. Genome-wide study links PNPLA3 variant with elevated hepatic transaminase after acute lymphoblastic leukemia therapy. Clinical Pharmacology and Therapeutics. PMID 28090653 DOI: 10.1002/Cpt.629  0.383
2017 Cheung YT, Khan RB, Liu W, Brinkman TM, Edelmann MN, Reddick WE, Pei D, Panoskaltsis-Mortari A, Srivastava D, Cheng C, Robison LL, Hudson MM, Pui C, Krull KR. Biomarkers of brain injury and neurologic outcomes in children treated with chemotherapy for acute lymphoblastic leukemia (ALL). Journal of Clinical Oncology. 35: 10521-10521. DOI: 10.1200/Jco.2017.35.15_Suppl.10521  0.314
2017 Chen A, Hu Y, Zheng X, Lu J, Xiao P, Yang J, Zhang Y, Sui P, Yang J, He F, He H, Wang Y, Wu C, Liu X, Zhou Y, ... ... Cheng C, et al. Clinical Outcomes and Mutation Clearance in Children with Acute Myeloid Leukemia Treated with Low-Dose Chemotherapy Plus G-CSF for Remission Induction Blood. 130: 1397-1397. DOI: 10.1182/Blood.V130.Suppl_1.1397.1397  0.391
2017 Meyer JA, Mason CC, Maese L, Pei D, Cheng C, Pui C, Greaves M, Aplenc R, Mulligan CG, Raetz E, Miles RR, Rabin KR, Schiffman JD. Abstract 4884: Focal 22q11.22 deletions combined withIKZF1alterations are associated with worse clinical outcome in acute lymphoblastic leukemia Cancer Research. 77: 4884-4884. DOI: 10.1158/1538-7445.Am2017-4884  0.309
2017 Li B, Li Y, Shen S, Zhu X, Ma X, Wang N, Liu Y, Liu Y, Zhang H, Lin T, Rusch M, Edmonson M, Easton J, Zhang Y, Zhang J, ... Cheng C, et al. Abstract 4870: Mutational landscape and timing of resistant clone emergence in 104 Chinese pediatric patients with relapsed acute lymphoblastic leukemia Cancer Research. 77: 4870-4870. DOI: 10.1158/1538-7445.Am2017-4870  0.307
2016 Portera MV, Karol SE, Smith C, Yang W, Cheng C, Neel MD, Pui CH, Relling MV, Kaste SC. Osteonecrosis is unrelated to hip anatomy in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer. PMID 28035753 DOI: 10.1002/Pbc.26407  0.344
2016 Stock W, Diouf B, Crews KR, Pei D, Cheng C, Laumann K, Mandrekar SJ, Luger S, Advani A, Stone RM, Larson RA, Evans WE. An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia. Clinical Pharmacology and Therapeutics. PMID 27618250 DOI: 10.1002/Cpt.506  0.351
2016 Liu YF, Wang BY, Zhang WN, Huang JY, Li BS, Zhang M, Jiang L, Li JF, Wang MJ, Dai YJ, Zhang ZG, Wang Q, Kong J, Chen B, Zhu YM, ... ... Cheng C, et al. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia. Ebiomedicine. 8: 173-183. PMID 27428428 DOI: 10.1016/J.Ebiom.2016.04.038  0.357
2016 Watts CS, Sciasci JN, Pauley JL, Panetta JC, Pei D, Cheng C, Christensen CM, Mikkelsen TS, Pui CH, Jeha S, Relling MV. Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate. Journal of Pediatric Hematology/Oncology. PMID 27322715 DOI: 10.1097/Mph.0000000000000606  0.307
2016 Nguyen R, Jeha S, Zhou Y, Cao X, Cheng C, Bhojwani D, Campbell P, Howard SC, Rubnitz J, Ribeiro RC, Sandlund JT, Gruber T, Inaba H, Pui CH, Metzger ML. The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. PMID 27187265 DOI: 10.1002/Pbc.26056  0.335
2016 Liu C, Yang W, Devidas M, Cheng C, Pei D, Smith C, Carroll WL, Raetz EA, Bowman WP, Larsen EC, Maloney KW, Martin PL, Mattano LA, Winick NJ, Mardis ER, et al. Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27114598 DOI: 10.1200/Jco.2015.64.5812  0.326
2016 Jacola LM, Krull KR, Pui CH, Pei D, Cheng C, Reddick WE, Conklin HM. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26858334 DOI: 10.1200/Jco.2015.64.3205  0.343
2016 Chellapandian D, Zhang R, Jeng M, Bos CVD, López VS, Lehmberg K, Sieni E, Wang Y, Nakano TA, Williams J, Fustino NJ, Astigarraga I, Dunkel I, An Q, Cheng C, et al. Hemophagocytic Lymphohistiocytosis (HLH) in Langerhans Cell Histiocytosis (LCH): A Multicenter Retrospective Descriptional Study Blood. 128: 707-707. DOI: 10.1182/Blood.V128.22.707.707  0.318
2016 Hu S, Zhu X, Yiping Z, Yu J, Cheng C, Liu X, Yuan A, Pei D, Yang J. Response to Prednisone Window Treatment Is a Universal Early Prognostic Marker in Chinese Children with T Lineage ALL Despite Outcome Disparity: A Multi-Center Experience Blood. 128: 5282-5282. DOI: 10.1182/Blood.V128.22.5282.5282  0.307
2016 Chen A, Hu Y, Liu X, Lu J, Xiao P, Zheng X, Yang J, Zhang Y, Yang J, He F, Sui P, He H, Wang Y, Cheng C, Ribeiro RC, et al. Clinical Outcome and Non-Synonymous Mutation Clearance in Chinese Children with Acute Myeloid Leukemia Treated with a Low-Intensity Induction Chemotherapy Regimen Blood. 128: 2848-2848. DOI: 10.1182/Blood.V128.22.2848.2848  0.348
2016 Liu C, Pei D, Cheng C, Yang JJ, Crews KR, Panetta JC, DeMeter X, Jeha S, Sandlund J, Ribeiro RC, Rubnitz JE, Metzger ML, Pui C, Evans WE, Relling MV. Asparaginase May Affect Mercaptopurine Tolerability in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia Blood. 128: 179-179. DOI: 10.1182/Blood.V128.22.179.179  0.339
2016 Jeha S, Metzger ML, Crews KR, Campbell P, Ribeiro RC, Cheng C, Peyton M, Panetta C, Yang J, Pui C, Bhojwani D. a Phase I Trial of Bendamustine in Combination with Clofarabine and Etoposide in Pediatric Patients with Relapsed or Refractory Hematologic Malignancies Blood. 128: 1628-1628. DOI: 10.1182/Blood.V128.22.1628.1628  0.321
2015 Hakim H, Dallas R, Zhou Y, Pei D, Cheng C, Flynn PM, Pui CH, Jeha S. Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia. Cancer. PMID 26700662 DOI: 10.1002/Cncr.29833  0.311
2015 Karol SE, Mattano LA, Yang W, Maloney KW, Smith C, Liu C, Ramsey LB, Fernandez CA, Chang TY, Neale G, Cheng C, Mardis E, Fulton R, Scheet P, San Lucas FA, et al. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood. PMID 26590194 DOI: 10.1182/Blood-2015-10-673848  0.374
2015 Moriyama T, Metzger ML, Wu G, Nishii R, Qian M, Devidas M, Yang W, Cheng C, Cao X, Quinn E, Raimondi S, Gastier-Foster JM, Raetz E, Larsen E, Martin PL, et al. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study. The Lancet. Oncology. PMID 26522332 DOI: 10.1016/S1470-2045(15)00369-1  0.334
2015 Karol SE, Yang W, Van Driest SL, Chang TY, Kaste S, Bowton E, Basford M, Bastarache L, Roden DM, Denny JC, Larsen E, Winick N, Carroll WL, Cheng C, Pei D, et al. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood. PMID 26265699 DOI: 10.1182/Blood-2015-05-643601  0.369
2015 Ramsey LB, Janke LJ, Payton MA, Cai X, Paugh SW, Karol SE, Kamdem Kamdem L, Cheng C, Williams RT, Jeha S, Pui CH, Evans WE, Relling MV. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia. Plos One. 10: e0135134. PMID 26252865 DOI: 10.1371/Journal.Pone.0135134  0.363
2015 Pui CH, Pei D, Coustan-Smith E, Jeha S, Cheng C, Bowman WP, Sandlund JT, Ribeiro RC, Rubnitz JE, Inaba H, Bhojwani D, Gruber TA, Leung WH, Downing JR, Evans WE, et al. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. The Lancet. Oncology. 16: 465-74. PMID 25800893 DOI: 10.1016/S1470-2045(15)70082-3  0.307
2015 Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, Wing C, Delaney SM, Komatsu M, Paugh SW, McCorkle JR, et al. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. Jama. 313: 815-23. PMID 25710658 DOI: 10.1001/Jama.2015.0894  0.355
2015 Scott JR, Zhou Y, Cheng C, Ward DA, Swanson HD, Molinelli AR, Stewart CF, Navid F, Jeha S, Relling MV, Crews KR. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients. Pediatric Blood & Cancer. 62: 1518-22. PMID 25631103 DOI: 10.1002/Pbc.25395  0.312
2015 Yang JJ, Landier W, Yang W, Liu C, Hageman L, Cheng C, Pei D, Chen Y, Crews KR, Kornegay N, Wong FL, Evans WE, Pui CH, Bhatia S, Relling MV. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1235-42. PMID 25624441 DOI: 10.1200/Jco.2014.59.4671  0.366
2015 Zhang J, McCastlain K, Qu C, Wu G, Edmonson M, Li Y, Wei L, Payne-Turner D, Yoshihara H, Churchman ML, Waanders E, Ntziachristos P, Aifantis I, Roberts KG, Ma J, ... ... Cheng C, et al. Expression of an Oncogenic ERG isoform Characterizes a Distinct Subtype of B-Progenitor Acute Lymphoblastic Leukemia Blood. 126: 693-693. DOI: 10.1182/Blood.V126.23.693.693  0.341
2015 Roberts KG, Payne-Turner D, McCastlain K, Gu Z, Iacobucci I, Harvey RC, Chen I, Valentine M, Pei D, Li Y, Zhang J, Cheng C, Rambaldi A, Spinelli O, Radich JP, et al. High Frequency and Poor Outcome of Ph-like Acute Lymphoblastic Leukemia in Adults Blood. 126: 2618-2618. DOI: 10.1182/Blood.V126.23.2618.2618  0.307
2014 Chhibber A, Kroetz DL, Tantisira KG, McGeachie M, Cheng C, Plenge R, Stahl E, Sadee W, Ritchie MD, Pendergrass SA. Genomic architecture of pharmacological efficacy and adverse events. Pharmacogenomics. 15: 2025-48. PMID 25521360 DOI: 10.2217/Pgs.14.144  0.315
2014 Sullivan EM, Jeha S, Kang G, Cheng C, Rooney B, Holladay M, Bari R, Schell S, Tuggle M, Pui CH, Leung W. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5986-94. PMID 25281696 DOI: 10.1158/1078-0432.Ccr-14-0479  0.342
2014 Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, McCastlain K, Ding L, Lu C, Song G, Ma J, Becksfort J, Rusch M, Chen SC, Easton J, ... ... Cheng C, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. The New England Journal of Medicine. 371: 1005-15. PMID 25207766 DOI: 10.1056/Nejmoa1403088  0.317
2014 Bhojwani D, Darbandi R, Pei D, Ramsey LB, Chemaitilly W, Sandlund JT, Cheng C, Pui CH, Relling MV, Jeha S, Metzger ML. Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. European Journal of Cancer (Oxford, England : 1990). 50: 2685-94. PMID 25087182 DOI: 10.1016/J.Ejca.2014.06.023  0.326
2014 Roberts KG, Pei D, Campana D, Payne-Turner D, Li Y, Cheng C, Sandlund JT, Jeha S, Easton J, Becksfort J, Zhang J, Coustan-Smith E, Raimondi SC, Leung WH, Relling MV, et al. Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3012-20. PMID 25049327 DOI: 10.1200/Jco.2014.55.4105  0.366
2014 Ramsey LB, Janke LJ, Edick MJ, Cheng C, Williams RT, Sherr CJ, Evans WE, Relling MV. Host thiopurine methyltransferase status affects mercaptopurine antileukemic effectiveness in a murine model. Pharmacogenetics and Genomics. 24: 263-71. PMID 24710003 DOI: 10.1097/Fpc.0000000000000044  0.307
2014 Bhojwani D, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, Krull KR, Inaba H, Rubnitz JE, Metzger ML, Howard SC, Ribeiro RC, Cheng C, Reddick WE, Jeha S, et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 949-59. PMID 24550419 DOI: 10.1200/Jco.2013.53.0808  0.371
2014 Jeha S, Coustan-Smith E, Pei D, Sandlund JT, Rubnitz JE, Howard SC, Inaba H, Bhojwani D, Metzger ML, Cheng C, Choi JK, Jacobsen J, Shurtleff SA, Raimondi S, Ribeiro RC, et al. Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia Cancer. 120: 1514-1519. PMID 24501014 DOI: 10.1002/Cncr.28598  0.316
2014 Kang G, Liu W, Cheng C, Wilson CL, Neale G, Yang JJ, Ness KK, Robison LL, Hudson MM, Srivastava K. Evaluation of two-step iterative resampling procedure for internal validation of genome-wide association studies Bmc Bioinformatics. 15: P34. DOI: 10.1186/1471-2105-15-S10-P34  0.308
2014 Koss C, Nance S, Connelly M, Ma J, Shelat A, Cotton A, An Q, Cheng C, Metzger ML, Jeha S, Rubnitz JE, Downing JR, Guy RK, Gruber TA. Targeted Inhibition of the MLL Transcriptional Complex By Proteosome Inhibitors Elicits a High Response Rate in Relapsed/Refractory MLL Rearranged Leukemia Blood. 124: 972-972. DOI: 10.1182/Blood.V124.21.972.972  0.352
2014 Liu C, Pei D, Cheng C, Yang JJ, Crews K, Yang W, Karol SE, Jeha S, Sandlund JT, Ribeiro RC, Rubnitz JE, Metzger ML, Pui C, Evans WE, Relling MV. Tolerability of 6-Mercaptopurine (6MP) in Patients with Thiopurine Methyltransferase (TPMT) Heterozygosity in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia (ALL) Blood. 124: 3722-3722. DOI: 10.1182/Blood.V124.21.3722.3722  0.332
2014 Chang T, Yang W, Sara VDL, Kaste SC, Bowten EA, Basford M, Bastarache L, Roden DM, Denny JC, Mattano LA, Larsen EC, Winick NJ, Carroll WL, Cheng C, Pei D, et al. Glutamate Receptor Polymorphisms Contribute to Glucocorticoid-Associated Osteonecrosis Blood. 124: 367-367. DOI: 10.1182/Blood.V124.21.367.367  0.379
2014 Ramsey LB, Robinson KM, Kawedia JD, Yang W, Liu C, Panetta JC, Jeha S, Bhojwani D, Metzger ML, Cheng C, Evans WE, Pui C, Relling MV. Abstract CT409: Dexamethasone (dex) and asparaginase increase triglycerides during acute lymphoblastic leukemia (ALL) therapy in children Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Ct409  0.32
2013 Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, Xu H, Gastier-Foster J, E S, Lim JY, Chen IM, Fan Y, Devidas M, Borowitz MJ, Smith C, et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nature Genetics. 45: 1494-8. PMID 24141364 DOI: 10.1038/Ng.2803  0.331
2013 Krull KR, Bhojwani D, Conklin HM, Pei D, Cheng C, Reddick WE, Sandlund JT, Pui CH. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2182-8. PMID 23650422 DOI: 10.1200/Jco.2012.46.7944  0.326
2013 Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, Torgerson DG, Dean M, Winick NJ, Martin PL, et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. Journal of the National Cancer Institute. 105: 733-42. PMID 23512250 DOI: 10.1093/Jnci/Djt042  0.357
2013 Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, Payne-Turner D, Churchman M, Andersson A, Chen SC, McCastlain K, Becksfort J, Ma J, Wu G, Patel SN, ... ... Cheng C, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nature Genetics. 45: 242-52. PMID 23334668 DOI: 10.1038/Ng.2532  0.319
2013 Ramsey LB, Panetta JC, Smith C, Yang W, Fan Y, Winick NJ, Martin PL, Cheng C, Devidas M, Pui CH, Evans WE, Hunger SP, Loh M, Relling MV. Genome-wide study of methotrexate clearance replicates SLCO1B1. Blood. 121: 898-904. PMID 23233662 DOI: 10.1182/Blood-2012-08-452839  0.325
2013 Roberts KG, Payne-Turner D, Pei D, Becksfort J, Harvey RC, Li Y, Song G, Cheng J, Ma J, Zhang J, Cheng C, Chen S, Chen IL, Devidas M, Larsen EC, et al. Integrated Genomic and Mutational Profiling Of Adolescent and Young Adult ALL Identifies a High Frequency Of BCR-ABL1-Like ALL with Very Poor Outcome Blood. 122: 825-825. DOI: 10.1182/Blood.V122.21.825.825  0.342
2013 Diouf B, Crews K, Lew G, Pei D, Cheng C, Bao J, Zheng J, Yang W, Fan Y, Paugh SW, McCorkle JR, Lu X, Winick NJ, Carroll WL, Loh ML, et al. Genome-Wide Association Analyses Identify Susceptibility Loci For Vincristine-Induced Peripheral Neuropathy In Children With Acute Lymphoblastic Leukemia Blood. 122: 618-618. DOI: 10.1182/Blood.V122.21.618.618  0.384
2013 Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, Xu H, Gastier-Fostier J, E S, Lim JY, Chen IL, Fan Y, Devidas M, Borowitz MJ, Smith C, et al. Inherited GATA3 genetic Variants Are Associated With Childhood BCR-ABL1-Like Acute Lymphoblastic Leukemia and Increased Risk Of Relapse Blood. 122: 617-617. DOI: 10.1182/Blood.V122.21.617.617  0.367
2013 Pei D, Devidas M, Cheng C, Yang W, Howard SC, Loh ML, Martin PL, Winick NJ, Bowman WP, Larsen EC, Carroll WL, Raetz EA, Bhojwani D, Jeha S, Pui C, et al. Risk Factors For Acute Pancreatitis In Patients With Acute Lymphoblastic Leukemia Blood. 122: 3868-3868. DOI: 10.1182/Blood.V122.21.3868.3868  0.347
2013 Li Y, Payne-Turner D, Harvey RC, Cheng J, Zhang J, Song G, Yang Y, Santiago-Morales N, Pei D, Cheng C, Ma J, Chen S, Rusch M, Gupta P, Devidas M, et al. Genomic Characterization and Experimental Modeling Of BCR-ABL1 -Like Acute Lymphoblastic Leukemia Blood. 122: 232-232. DOI: 10.1182/Blood.V122.21.232.232  0.353
2012 Yang JJ, Cheng C, Devidas M, Cao X, Campana D, Yang W, Fan Y, Neale G, Cox N, Scheet P, Borowitz MJ, Winick NJ, Martin PL, Bowman WP, Camitta B, et al. Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood. 120: 4197-204. PMID 23007406 DOI: 10.1182/Blood-2012-07-440107  0.41
2012 Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. Journal of the National Cancer Institute. 104: 1386-95. PMID 22927505 DOI: 10.1093/Jnci/Djs344  0.328
2012 Stocco G, Yang W, Crews KR, Thierfelder WE, Decorti G, Londero M, Franca R, Rabusin M, Valsecchi MG, Pei D, Cheng C, Paugh SW, Ramsey LB, Diouf B, McCorkle JR, et al. PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Human Molecular Genetics. 21: 4793-804. PMID 22846425 DOI: 10.1093/Hmg/Dds302  0.378
2012 Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale G, Scheet P, Burchard EG, Torgerson DG, Eng C, Dean M, Antillon F, Winick NJ, Martin PL, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 751-7. PMID 22291082 DOI: 10.1200/Jco.2011.38.0345  0.349
2012 Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, ... ... Cheng C, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 481: 157-63. PMID 22237106 DOI: 10.1038/Nature10725  0.342
2012 Kawedia JD, Liu C, Pei D, Cheng C, Fernandez CA, Howard SC, Campana D, Panetta JC, Bowman WP, Evans WE, Pui CH, Relling MV. Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia. Blood. 119: 1658-64. PMID 22117041 DOI: 10.1182/Blood-2011-09-381731  0.345
2012 Inaba H, Bhojwani D, Pauley JL, Pei D, Cheng C, Metzger ML, Howard SC, Rubnitz JE, Sandlund JT, Ribeiro RC, Leung W, Campana D, Pui CH, Jeha S. Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. British Journal of Haematology. 156: 275-9. PMID 21883141 DOI: 10.1111/J.1365-2141.2011.08847.X  0.33
2012 Yang JJ, Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, Torgerson DG, Dean M, Winick N, et al. Genome-Wide Association Study Identifies a Novel Susceptibility Locus At 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethinically Diverse Populations Blood. 120: 877-877. DOI: 10.1182/Blood.V120.21.877.877  0.362
2012 Ramsey LB, Janke L, Edick M, Cheng C, Williams RT, Sherr CJ, Evans WE, Relling MV. Host Thiopurine Methyltransferase Status Affects Mercaptopurine Antileukemic Effectiveness Blood. 120: 3560-3560. DOI: 10.1182/Blood.V120.21.3560.3560  0.317
2012 Ramsey LB, Panetta JC, Smith C, Yang W, Fan Y, Winick N, Martin PL, Cheng C, Devidas M, Pui C, Evans WE, Hunger SP, Loh ML, Relling MV. A Genome-Wide Analysis of Variants Influencing Methotrexate Clearance Replicates SLCO1B1. Blood. 120: 2466-2466. DOI: 10.1182/Blood.V120.21.2466.2466  0.381
2012 Holmfeldt L, Diaz-Flores E, Zhang J, Payne-Turner D, Andersson A, Chen S, Becksfort J, Ma J, Wei L, Easton J, Pei D, Cheng C, Pui C, Devidas M, Carroll AJ, et al. Abstract 4870: Integrated genomic analysis of hypodiploid acute lymphoblastic leukemia Cancer Research. 72: 4870-4870. DOI: 10.1158/1538-7445.Am2012-4870  0.336
2011 Diouf B, Cheng Q, Krynetskaia NF, Yang W, Cheok M, Pei D, Fan Y, Cheng C, Krynetskiy EY, Geng H, Chen S, Thierfelder WE, Mullighan CG, Downing JR, Hsieh P, et al. Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells. Nature Medicine. 17: 1298-303. PMID 21946537 DOI: 10.1038/Nm.2430  0.311
2011 Mikkelsen TS, Sparreboom A, Cheng C, Zhou Y, Boyett JM, Raimondi SC, Panetta JC, Bowman WP, Sandlund JT, Pui CH, Relling MV, Evans WE. Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1771-8. PMID 21444869 DOI: 10.1200/Jco.2010.32.5340  0.33
2011 Brennan RC, Helton KJ, Pei D, Cheng C, Inaba H, Metzger ML, Howard SC, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Pui CH, Bhojwani D. Spinal epidural lipomatosis in children with hematologic malignancies. Annals of Hematology. 90: 1067-74. PMID 21340722 DOI: 10.1007/S00277-011-1183-6  0.325
2011 Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, Campana D, Yang W, Neale G, Cox NJ, Scheet P, Borowitz MJ, Winick NJ, Martin PL, Willman CL, Bowman WP, et al. Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nature Genetics. 43: 237-41. PMID 21297632 DOI: 10.1038/Ng.763  0.386
2011 Pui CH, Pei D, Campana D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Coustan-Smith E, Jeha S, Cheng C, Metzger ML, Bhojwani D, Inaba H, Raimondi SC, et al. Improved prognosis for older adolescents with acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 386-91. PMID 21172890 DOI: 10.1200/Jco.2010.32.0325  0.324
2011 Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, Neale G, Howard SC, Evans WE, Pui CH, Relling MV. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 117: 2340-7; quiz 2556. PMID 21148812 DOI: 10.1182/Blood-2010-10-311969  0.368
2011 Mangum DS, Shams S, Downie JM, von Schwedler U, Rodic V, Engel M, Barnette P, Frazer JK, Trede N, Pei D, Cheng C, Pui C, Hunger SP, Yang JJ, Miles RR, et al. Focal 22q11.22 Loss Combined with IKZF1 Alterations Predict Very Poor Outcome in Childhood Acute Lymphoblastic Leukemia Blood. 118: 741-741. DOI: 10.1182/Blood.V118.21.741.741  0.345
2011 Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen S, Collins-Underwood R, Ma J, Roberts KG, ... ... Cheng C, et al. Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project Blood. 118: 68-68. DOI: 10.1182/Blood.V118.21.68.68  0.364
2011 Ramsey LB, Bruun GH, Yang W, Trevino LR, Vattathil S, Scheet P, Cheng C, Rosner G, Giacomini K, Fan Y, Sparreboom A, Mikkelsen T, Corydon TJ, Pui C, Evans WE, et al. SLCO1B1 Variation and Methotrexate Disposition in Children with Acute Lymphoblastic Leukemia: The Importance of Rare Variants in Pharmacogenetics Blood. 118: 571-571. DOI: 10.1182/Blood.V118.21.571.571  0.379
2011 Kawedia JD, Liu C, Pei D, Cheng C, Fernandez CA, Howard SC, Campana D, Panetta JC, Bowman WP, Evans WE, Pui C, Relling MV. Systemic Exposure to Dexamethasone and Asparaginase Affects Risk of Relapse in Children with Acute Lymphoblastic Leukemia Blood. 118: 2550-2550. DOI: 10.1182/Blood.V118.21.2550.2550  0.362
2011 Liu C, Kawedia JD, Cheng C, Pei D, Fernandez CA, Cai X, Crews K, Kaste S, Panetta JC, Bowman WP, Jeha S, Sandlund J, Evans WE, Pui C, Relling MV. Clinical Utility and Implications of Asparaginase Antibodies in Acute Lymphoblastic Leukemia Blood. 118: 1481-1481. DOI: 10.1182/Blood.V118.21.1481.1481  0.313
2010 Chen SH, Pei D, Yang W, Cheng C, Jeha S, Cox NJ, Evans WE, Pui CH, Relling MV. Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. Clinical Pharmacology and Therapeutics. 88: 191-6. PMID 20592726 DOI: 10.1038/Clpt.2010.94  0.317
2010 Yang J, Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale GA, Winick NJ, Martin PL, Willman CL, Camitta BM, Reaman GH, Carroll WL, Loh M, et al. ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Blood. 116: 8-8. DOI: 10.1182/Blood.V116.21.8.8  0.359
2010 Figueroa ME, Chen S, Andersson AK, Liu W, Cheng C, Phillips LA, Li Y, Downing JR, Melnick AM, Mullighan C. Integrated Genetic and Epigenetic Analysis of Childhood Acute Lymphoblastic Leukemia Reveals a Synergistic Role for Structural and Epigenetic Lesions In Determining Disease Phenotype Blood. 116: 537-537. DOI: 10.1182/Blood.V116.21.537.537  0.314
2010 Jeha S, Pei D, Campana D, Bowman WP, Sandlund J, Kaste S, Ribeiro RC, Rubnitz JE, Coustan-Smith E, Cheng C, Metzger ML, Bhojwani D, Inaba H, Raimondi SC, Onciu M, et al. Improved Prognosis for Older Adolescents with Acute Lymphoblastic Leukemia Blood. 116: 498-498. DOI: 10.1182/Blood.V116.21.498.498  0.344
2010 Bhojwani D, Pei D, Sandlund J, Jeha S, Ribeiro RC, Rubnitz JE, Raimondi SC, Shurtleff S, Onciu M, Cheng C, Coustan-Smith E, Bowman WP, Howard SC, Metzger ML, Inaba H, et al. Excellent Outcome for ETV6/RUNX1-Positive Childhood Acute Lymphoblastic Leukemia (ALL) with Contemporary Therapy Blood. 116: 495-495. DOI: 10.1182/Blood.V116.21.495.495  0.386
2009 Treviño LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, Chan D, Sparreboom A, Giacomini KM, Pui CH, Evans WE, Relling MV. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5972-8. PMID 19901119 DOI: 10.1200/Jco.2008.20.4156  0.319
2009 Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. The New England Journal of Medicine. 360: 2730-41. PMID 19553647 DOI: 10.1056/Nejmoa0900386  0.367
2009 Jeha S, Pei D, Raimondi SC, Onciu M, Campana D, Cheng C, Sandlund JT, Ribeiro RC, Rubnitz JE, Howard SC, Downing JR, Evans WE, Relling MV, Pui CH. Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia. 23: 1406-9. PMID 19282835 DOI: 10.1038/Leu.2009.42  0.346
2009 Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, Cheng C, Su X, Rubnitz JE, Basso G, Biondi A, Pui CH, Downing JR, Campana D. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia Lancet Oncology. 10: 147-156. PMID 19147408 DOI: 10.1016/S1470-2045(08)70314-0  0.385
2009 Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Schulman BA, Harvey RC, Chen IM, Clifford RJ, Carroll WL, Reaman G, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. The New England Journal of Medicine. 360: 470-80. PMID 19129520 DOI: 10.1056/Nejmoa0808253  0.346
2009 French D, Yang W, Cheng C, Raimondi SC, Mullighan CG, Downing JR, Evans WE, Pui CH, Relling MV. Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia. Blood. 113: 4512-20. PMID 19066393 DOI: 10.1182/Blood-2008-07-172106  0.354
2009 Chen S, Pei D, Yang W, Cheng C, Jeha S, Evans WE, Pui C, Relling MV. Genetic Variations in GRIA1 On Chromosome 5q33 Related to Asparaginase Hypersensitivity in Childhood Acute Lymphoblastic Leukemia (ALL). Blood. 114: 112-112. DOI: 10.1182/Blood.V114.22.112.112  0.345
2008 Pottier N, Yang W, Assem M, Panetta JC, Pei D, Paugh SW, Cheng C, Den Boer ML, Relling MV, Pieters R, Evans WE, Cheok MH. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. Journal of the National Cancer Institute. 100: 1792-803. PMID 19066270 DOI: 10.1093/Jnci/Djn416  0.339
2008 Jones TS, Kaste SC, Liu W, Cheng C, Yang W, Tantisira KG, Pui CH, Relling MV. CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3031-7. PMID 18565889 DOI: 10.1200/Jco.2007.14.6399  0.301
2008 Kamdem LK, Hamilton L, Cheng C, Liu W, Yang W, Johnson JA, Pui CH, Relling MV. Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia. Pharmacogenetics and Genomics. 18: 507-14. PMID 18496130 DOI: 10.1097/Fpc.0B013E3282Fc5801  0.341
2008 Yang L, Panetta JC, Cai X, Yang W, Pei D, Cheng C, Kornegay N, Pui CH, Relling MV. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1932-9. PMID 18421047 DOI: 10.1200/Jco.2007.13.8404  0.348
2008 Sorich MJ, Pottier N, Pei D, Yang W, Kager L, Stocco G, Cheng C, Panetta JC, Pui CH, Relling MV, Cheok MH, Evans WE. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. Plos Medicine. 5: e83. PMID 18416598 DOI: 10.1371/Journal.Pmed.0050083  0.427
2008 Anghelescu DL, Burgoyne LL, Liu W, Hankins GM, Cheng C, Beckham PA, Shearer J, Norris AL, Kun LE, Bikhazi GB. Safe Anesthesia for Radiotherapy in Pediatric Oncology: St. Jude Children's Research Hospital Experience, 2004–2006 International Journal of Radiation Oncology Biology Physics. 71: 491-497. PMID 18207663 DOI: 10.1016/J.Ijrobp.2007.09.044  0.318
2008 Hargrove PW, Kepes S, Hanawa H, Obenauer JC, Pei D, Cheng C, Gray JT, Neale G, Persons DA. Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 525-33. PMID 18195719 DOI: 10.1038/Sj.Mt.6300394  0.302
2008 Ware RE, He J, Mortier NA, Howard TA, Cheng C, Flanagan JM, Sparreboom A. Distinct Phenotypes of Hydroxyurea Absorption among Children with Sickle Cell Anemia Blood. 112: 709-709. DOI: 10.1182/Blood.V112.11.709.709  0.319
2008 Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Harvey RC, Chen I, Clifford R, Carroll WL, Reaman G, Devidas M, et al. Deletion of IKZF1 (Ikaros) Predicts Poor Outcome and Impaired Maturation in B-Progenitor Acute Lymphoblastic Leukemia Blood. 112: 427-427. DOI: 10.1182/Blood.V112.11.427.427  0.384
2008 Trevino LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, Chan D, Sparreboom A, Giacomini KM, Pui C, Evans WE, Relling MV. A Whole Genome Analysis Identifies SLCO1B1 as a Determinant of Methotrexate Pharmacokinetics and Adverse Effects Blood. 112: 214-214. DOI: 10.1182/Blood.V112.11.214.214  0.35
2008 Yang JJ, Yang W, Cheng C, Devidas M, Cao X, Campana D, Borowitz MJ, Willman CL, Bowman WP, Reaman G, Carroll WL, Hunger SP, Evans WE, Pui C, Relling MV. Genetically Defined Racial Differences Underlie Risk of Relapse in Childhood Acute Lymphoblastic Leukemia Blood. 112: 14-14. DOI: 10.1182/Blood.V112.11.14.14  0.371
2008 Flotho C, Coustan-Smith E, Pei D, Cheng C, Song G, Pui C, Downing JR, Campana D. Response: Genes associated with response to therapy in childhood acute lymphoblastic leukemia Blood. 111: 2487-2488. DOI: 10.1182/Blood-2007-11-125732  0.364
2007 Flotho C, Coustan-Smith E, Pei D, Cheng C, Song G, Pui C, Downing JR, Campana D. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia Blood. 110: 1271-1277. PMID 17456722 DOI: 10.1182/Blood-2007-01-068478  0.388
2007 Kishi S, Cheng C, French D, Pei D, Das S, Cook EH, Hijiya N, Rizzari C, Rosner GL, Frudakis T, Pui CH, Evans WE, Relling MV. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood. 109: 4151-7. PMID 17264302 DOI: 10.1182/Blood-2006-10-054528  0.351
2007 Stocco G, Cheok M, Yang W, Dervieux T, Crews K, Pei D, Cheng C, Pui C, Relling MV, Evans WE. Inosine-Triphosphate-Pyrophosphatase Genotype Is a Determinant of Severe Fever with Neutropenia Following Treatment of Acute Lymphoblastic Leukemia with Combination Chemotherapy That Includes Mercaptopurine Adjusted for Thiopurine-S-Methyltransferase Genotype. Blood. 110: 2827-2827. DOI: 10.1182/Blood.V110.11.2827.2827  0.358
2007 Yang J, Bogni A, Cheng C, Bleibel WK, Cai J, Fan Y, Yang W, Rocha JC, Pei D, Liu W, Dolan ME, Pui C, Relling MV. Etoposide Sensitivity Does Not Predict MLL Rearrangements or Risk of Therapy-Related Acute Myeloid Leukemia. Blood. 110: 1829-1829. DOI: 10.1182/Blood.V110.11.1829.1829  0.367
2006 Jeha S, Behm F, Pei D, Sandlund JT, Ribeiro RC, Razzouk BI, Rubnitz JE, Hijiya N, Howard SC, Cheng C, Pui CH. Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia Blood. 108: 3302-3304. PMID 16896151 DOI: 10.1182/Blood-2006-04-016709  0.31
2006 Nasedkina TV, Fedorova OE, Glotov AS, Chupova NV, Samochatova EV, Maiorova OA, Zemlyakova VV, Roudneva AE, Chudinov AV, Yurasov RA, Kozhekbaeva JM, Barsky VE, Krynetskiy EY, Krynetskaia NF, Cheng C, et al. Rapid genotyping of common deficient thiopurine S-methyltransferase alleles using the DNA-microchip technique European Journal of Human Genetics. 14: 991-998. PMID 16724002 DOI: 10.1038/Sj.Ejhg.5201647  0.317
2006 Flotho C, Coustan-Smith E, Pei D, Iwamoto S, Song G, Cheng C, Pui C, Downing JR, Campana D. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2. Blood. 108: 1050-1057. PMID 16627760 DOI: 10.1182/Blood-2006-01-0322  0.383
2006 Relling MV, Pui CH, Cheng C, Evans WE. Thiopurine methyltransferase in acute lymphoblastic leukemia [4] Blood. 107: 843-844. PMID 16401827 DOI: 10.1182/Blood-2005-08-3379  0.368
2006 Holleman A, Den Boer ML, De Menezes RX, Cheok MH, Cheng C, Kazemier KM, Janka-Schaub GE, Göbel U, Graubner UB, Evans WE, Pieters R. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia Blood. 107: 769-776. PMID 16189266 DOI: 10.1182/Blood-2005-07-2930  0.376
2006 Cheng Q, Cheng C, Crews KR, Ribeiro RC, Pui C, Relling MV, Evans WE. Epigenetic Regulation of Human γ-Glutamyl Hydrolase Activity in Acute Lymphoblastic Leukemia Cells American Journal of Human Genetics. 87: 264-274. DOI: 10.1016/J.Ajhg.2010.06.011  0.321
2005 Pui CH, Pei D, Sandlund JT, Campana D, Ribeiro RC, Razzouk BI, Rubnitz JE, Howard SC, Hijiya N, Jeha S, Cheng C, Downing JR, Evans WE, Relling MV, Hudson M. Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia Journal of Clinical Oncology. 23: 7936-7941. PMID 16258093 DOI: 10.1200/Jco.2004.01.0033  0.344
2005 Lugthart S, Cheok MH, Boer MLd, Yang W, Holleman A, Cheng C, Pui C, Relling MV, Janka-Schaub GE, Pieters R, Evans WE. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia Cancer Cell. 7: 375-386. PMID 15837626 DOI: 10.1016/J.Ccr.2005.03.002  0.402
2005 Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH, Sandlund JT, Rubnitz J, Ribeiro R, Campana D, Pui CH, Evans WE, Relling MV. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood. 105: 4752-8. PMID 15713801 DOI: 10.1182/Blood-2004-11-4544  0.386
2005 Edick MJ, Cheng C, Yang W, Cheok M, Wilkinson MR, Pei D, Evans WE, Kun LE, Pui C, Relling MV. Lymphoid gene expression as a predictor of risk of secondary brain tumors. Genes, Chromosomes and Cancer. 42: 107-116. PMID 15543619 DOI: 10.1002/Gcc.20121  0.334
2005 Flotho C, Coustan-Smith E, Song G, Cheng C, Pei D, Pui C, Downing JR, Campana D. Genome-Wide Expression Profiling and Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia. Blood. 106: 87-87. DOI: 10.1182/Blood.V106.11.87.87  0.387
2005 Hartford CM, Yang W, Cheng C, Pounds S, Liu W, Su X, Neale G, Raimondi SC, Pui C, Relling MV. Genome Scan for Therapy-Related Leukemia. Blood. 106: 3254-3254. DOI: 10.1182/Blood.V106.11.3254.3254  0.354
2005 Jeha S, Cheng C, Sandlund J, Ribeiro R, Razzouk B, Rubnitz J, Hijiya N, Howard S, Behm F, Pui C. Prognostic Significance of CD20 in Children with B-Precursor Acute Lymphoblastic Leukemia. Blood. 106: 1452-1452. DOI: 10.1182/Blood.V106.11.1452.1452  0.31
2004 Holleman A, Cheok MH, Boer MLd, Yang W, Veerman AJP, Kazemier KM, Pei D, Cheng C, Pui C, Relling MV, Janka-Schaub GE, Pieters R, Evans WE. Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment The New England Journal of Medicine. 351: 533-542. PMID 15295046 DOI: 10.1056/Nejmoa033513  0.347
2004 Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk BI, Howard SC, Hudson MM, Cheng C, Kun LE, Raimondi SC, Behm FG, Downing JR, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood. 104: 2690-6. PMID 15251979 DOI: 10.1182/Blood-2004-04-1616  0.372
2004 Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G, Shurtleff SA, Pounds S, Cheng C, Ma J, Ribeiro RC, Rubnitz JE, Girtman K, Williams WK, Raimondi SC, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood. 104: 3679-87. PMID 15226186 DOI: 10.1182/Blood-2004-03-1154  0.37
2004 Zaza G, Yang W, Kager L, Cheok M, Downing J, Pui C, Cheng C, Relling MV, Evans WE. Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis Blood. 104: 1435-1441. PMID 15142881 DOI: 10.1182/Blood-2003-12-4306  0.348
2004 Zaza G, Cheok M, Yang W, Deqing P, Cheng C, Pui C, Relling MV, Evans WE. Identification of Gene Expression Profiles in Acute Lymphoblastic Leukemia Cells That Discriminate Intracellular Thioguanine Nucleotide Accumulation in ALL Cells after In Vivo Treatment with Mercaptopurine. Blood. 104: 453-453. DOI: 10.1182/Blood.V104.11.453.453  0.37
2004 Bogni A, Cheng C, Liu W, Yang W, French D, Mukatira S, Downing JR, Pui C, Relling M. Gene Expression Profiles Distinguish Children Who Develop Therapy-Related Myeloid Leukemia. Blood. 104: 397-397. DOI: 10.1182/Blood.V104.11.397.397  0.359
2004 Kishi S, Cheng C, Pei D, Das S, Cook EH, Hijiya N, Rizzari C, Rosner G, Pui C, Evans WE, Relling MV. Genetic Polymorphisms and the Toxicity of Antileukemic Agents in Children with Acute Lymphoblastic Leukemia. Blood. 104: 1964-1964. DOI: 10.1182/Blood.V104.11.1964.1964  0.38
2004 Cheok MH, Ding C, Yang W, Das S, Campana D, Cheng C, Cook EH, Pui C, Relling MV, Evans WE. Genetic Polymorphisms in the Promoter Region of the beta-2 Adrenergic Receptor Are Associated with the Early Response of Acute Lymphoblastic Leukemia to Chemotherapy. Blood. 104: 1959-1959. DOI: 10.1182/Blood.V104.11.1959.1959  0.405
2003 Pui CH, Sandlund JT, Pei D, Rivera GK, Howard SC, Ribeiro RC, Rubnitz JE, Razzouk BI, Hudson MM, Cheng C, Raimondi SC, Behm FG, Downing JR, Relling MV, Evans WE. Results of therapy for acute lymphoblastic leukemia in black and white children. Jama. 290: 2001-7. PMID 14559953 DOI: 10.1001/Jama.290.15.2001  0.354
2003 Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, Ribeiro RC, Relling MV, Kun LE, Evans WE, Hudson MM. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. The New England Journal of Medicine. 349: 640-9. PMID 12917300 DOI: 10.1056/Nejmoa035091  0.327
2003 Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, Hudson M, Rubnitz J, Sandlund JT, Pui C, Relling MV. Homocysteine, Pharmacogenetics, and Neurotoxicity in Children With Leukemia Journal of Clinical Oncology. 21: 3084-3091. PMID 12915598 DOI: 10.1200/Jco.2003.07.056  0.364
2002 Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 1: 133-43. PMID 12086872 DOI: 10.1016/S1535-6108(02)00032-6  0.372
Show low-probability matches.